Transplantation and cellular therapy
Efficacy and Safety of Romiplostim in Treating Thrombocytopenia after Hematopoietic Stem Cell Transplantation in Pediatric Patients: A Single-Arm Clinical Trial.
Zahra Karimizadeh, Maryam Behfar, Atieh Karimzadeh, Leila Jafari, Amirali Kalantari, Zeynab Nikfetrat, Amir Ali Hamidieh
Published: 202610.1016/j.jtct.2025.12.1003
Abstract
Prolonged thrombocytopenia after hematopoietic stem cell transplantation (HSCT) in pediatric patients is associated with significant morbidity, including increased transfusion dependency, bleeding events, and reduced survival. Romiplostim (Nplate, Am…
Preview only. Read the full abstract at the source